Core Viewpoint - Recently, China Medical University announced procurement intentions for 21 items of laboratory equipment, with a total budget of 98.98 million yuan, scheduled for procurement between April and December 2025 [2][3]. Summary by Categories Procurement Overview - The procurement includes advanced equipment such as a holographic non-labeling 3D live cell tomography imaging system, cell energy metabolism analyzer, nanoscale large field three-dimensional combined system, ultracentrifuge, fully automated 3D cell culture instrument, and third-generation gene sequencer [3][4]. Equipment Details - **Fully Automated 3D Cell Culture Instrument**: Integrates automation control, real-time monitoring, and 3D cell culture technology, widely used in tissue engineering, regenerative medicine, drug screening, tumor research, and precision medicine. It simulates in vivo physiological environments better than traditional 2D cell culture [4]. - **Multispectral Super-Resolution Inverted Fluorescence Microscope**: An advanced imaging platform in life sciences, featuring high spatial resolution and multi-channel spectral capabilities, applicable in cell biology, neuroscience, cancer research, developmental biology, and drug development [5]. - **Cell Energy Metabolism Analyzer**: Monitors cell energy metabolism states in real-time, applicable in cancer biology, immunology, stem cell research, drug development, and metabolic diseases. It measures glycolysis and mitochondrial respiration activities [6]. Detailed Procurement List - The procurement list includes various advanced instruments with specific budget allocations, such as: - Holographic 3D live cell imaging system: 17.8 million yuan - Cell energy metabolism analyzer: 26 million yuan - Nanoscale large field three-dimensional combined system: 12 million yuan - Ultracentrifuge: 8.5 million yuan - Fully automated 3D cell culture instrument: 6.5 million yuan - Third-generation gene sequencer: 7.5 million yuan - Multispectral super-resolution inverted fluorescence microscope: 8.5 million yuan [9][10]. Application and Impact - The procurement aims to enhance research capabilities in various fields, including biomedicine, cell biology, and tissue engineering, thereby supporting the development of high-end talent and scientific research at the university [11].